Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy and irradiation interaction.

Hak Choy1, Dong W Kim

  • 1Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Seminars in Oncology
|August 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ACL Mucoid Degeneration-Anterior and Posterior Arthroscopic Decompression for Combined Knee Flexion-Extension Deficit.

Arthroscopy techniques·2023
Same author

Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by <sup>18</sup>F-FDG PET/CT Imaging Following CAR-T Therapy.

Clinical lymphoma, myeloma & leukemia·2023
Same author

Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea.

Advances in therapy·2023
Same author

Reply to: Existing methods are effective at measuring natural selection on gene expression.

Nature ecology & evolution·2022
Same author

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer.

Advances in radiation oncology·2022
Same author

Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.

European urology oncology·2022
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Concurrent chemoradiotherapy combines chemotherapy and radiation to improve cancer survival and local control. This review explores the biological basis, drug-radiation interactions, and emerging strategies for this effective cancer treatment.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Concurrent chemoradiotherapy is a cornerstone of modern cancer treatment.
  • It offers improved survival and locoregional control over radiotherapy alone for various cancers.
  • A strong biological rationale underpins its efficacy.

Purpose of the Study:

  • To review the biological rationale and fundamental principles of chemoradiotherapy.
  • To discuss the mechanistic interactions between chemotherapeutic agents and radiation.
  • To present novel compounds and emerging strategies in chemoradiotherapy.

Main Methods:

  • Review of existing literature on chemoradiotherapy.
  • Analysis of mechanistic interactions between chemotherapy and radiation.

Related Experiment Videos

  • Identification and presentation of novel chemotherapeutic agents and treatment strategies.

    • Main Results:

    • Concurrent chemoradiotherapy demonstrates superior outcomes compared to radiotherapy alone.
    • Understanding drug-radiation interactions is crucial for optimizing treatment.
    • Several chemotherapeutic agents enhance tumor response to radiation.

    Conclusions:

    • Concurrent chemoradiotherapy is a highly effective cancer treatment modality.
    • Further research into drug-radiation mechanisms will refine treatment strategies.
    • Emerging compounds and strategies hold promise for advancing chemoradiotherapy.